Skip to main content
[Preprint]. 2026 Sep 22:2026.09.12.26362500. Originally published 2026 Sep 20. [Version 2] doi: 10.64898/2026.09.12.26362500

Table 2:

Cox Proportional Hazards Regression Model Assessing Interaction of CTX-Benefit Subgroup with Chemotherapy Benefit in RS-Intermediate Patients.

CTX-Benefit Subgroup Hazard ratio (95% CI) Likelihood ratio test on interaction, p-value
CTX-Benefit-low 1.033 (0.766–1.392) 0.016
CTX-Benefit-high 0.534 (0.313–0.912)